IUC26589-95

Abstract Code: IUC26589-95   First-Line or Maintenance Immune Checkpoint Inhibitors in Older Patients with Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis Incognito 1, A. D’arienzo 2, C. Barraco 2, A. Nicastro 2, S. Facchini 3, G....

IUC26569-93

Abstract Code: IUC26569-93   Enfortumab-Vedotin with Pembrolizumab vs platinum-based therapy for advanced urothelial cancer in Oxford. Al Kharusi 1, S. San Ti 1, A. Protheroe 1, M. Tuthill 1 (1) Oxford University Hospitals NHS Foundation Trust – United...

IUC26529-89

Abstract Code: IUC26529-89   Sex Differences in Enfortumab Vedotin Efficacy and NECTIN-4 Levels in Metastatic Urothelial Cancer Taha 1, A. Alpert 2, A. Rizzo 3, F. Ciccimarra 3, J. Bellmunt 4, S. Gupta 5, R. Kanesvaran 6, Y. Urun 7, M. Santoni 8, I. Waldhorn 2...

IUC25980-89

Abstract Code: IUC25980-89   Impact of Ureteroscopy on Diagnostic Pathways and Radical Nephroureterectomy Outcomes in Upper Tract Urothelial Carcinoma Maleki 1, L.F.C. Yu 1, H. Janebdar 1, J. Armitage 1 (1) Addenbrooke’s Hospital, Cambridge – United...

IUC25722-83

Abstract Code: IUC25722-83   Bladder Cancer in Young Women: Clinicopathological Features and Risk Factors from a Multi-Center Retrospective Study Saberi 1, Y. Ahmad 2, N. Mahmoud Nejad 3, M.H. Izadpanahi 4, A. Behnamfar 1, A. Javid 1, F. Rajaee Rizi 5 (1)...

IUC25665-89

Abstract Code: IUC25665-89   BK Virus Associated Urothelial Carcinoma – A Regional Cohort of Kidney Transplant Recipients Beetge 1, L. Ribeiro 2, C. Horsfield 2, R. Zakri 2, J. Olsburgh 2 (1) King’s College London – United Kingdom, (2) Guy’s and...
error: Content is protected !!